SIRS-Lab, the innovative molecular diagnostics company specialized in sepsis, today announced the successful completion of recruitment in its 1'000-patient trial. The prospective, blinded multicenter ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Between 2013 and 2018, rates of antibiotic use and sepsis decreased in 152 hospitals, diminishing fears that sepsis improvement efforts will lead to antibiotic overuse. Hospitals and policymakers ...

Investigators created a model for predicting the risk of urinary sepsis after endoscopic surgery for urinary stones using several key variables. A model incorporating values of stone composition and ...

Barcelona, Spain: Two out of the four internationally-recommended screening tools used by emergency medical services are inadequate for recognising sepsis, according to new research presented at the ...

Doctors in Liverpool working with researchers at the Center for Trials Research at Cardiff University have identified ...

Use of a sepsis predictor made little difference in time to antibiotic administration for septic patients in the emergency department, based on data from more than 200 patients. "One of the big ...

Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced its participation, including the presentation of a poster, at the ...